Abstract
Over decades, reports of autologous tumor-infiltrating lymphocytes inducing partial and even complete responses in treatment-refractory tumors has spurred investigation into methods for refining and improving this process. Zacharias etal.1 report two partial and one complete response from a phase II study utilizing neoantigen-reactive TILs in patients with metastatic breast cancer.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call